Ionis Pharmaceuticals: RBC Capital Maintains Outperform, Raises PT to $82 from $80.

jueves, 30 de octubre de 2025, 11:40 am ET1 min de lectura
IONS--

Ionis Pharmaceuticals: RBC Capital Maintains Outperform, Raises PT to $82 from $80.

Ionis Pharmaceuticals: RBC Capital Maintains Outperform, Raises PT to $82 from $80.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios